Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?

Reiber’s diagram biomarker cerebrospinal fluid hyperbolic function kappa free light chains multiple sclerosis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
16 Nov 2019
Historique:
received: 03 10 2019
revised: 01 11 2019
accepted: 12 11 2019
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 21 11 2019
Statut: epublish

Résumé

Oligoclonal bands are the gold standard for determination of an intrathecal immunoglobulin G synthesis and were recently included in the McDonald criteria of 2017 to diagnose relapsing multiple sclerosis (MS) as a substitute for dissemination in time. Intrathecally produced kappa free light chains (KFLC) are a novel promising biomarker with similar characteristics and the advantage for automated determination. However, different approaches exist to determine the intrathecal KFLC fraction. The most common method is to calculate the CSF/serum KFLC quotient with reference to the albumin CSF/serum quotient (Q

Identifiants

pubmed: 31744096
pii: diagnostics9040194
doi: 10.3390/diagnostics9040194
pmc: PMC6963502
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Mol Sci. 2016 Sep 21;17(9):
pubmed: 27657060
Clin Chem. 1995 Feb;41(2):256-63
pubmed: 7874779
Front Neurol. 2019 Mar 15;10:188
pubmed: 30930829
Int J Mol Sci. 2017 Sep 27;18(10):
pubmed: 28953254
J Neurol. 2008 Oct;255(10):1508-14
pubmed: 18685917
Front Immunol. 2019 Mar 29;10:641
pubmed: 30984199
J Neuroimmunol. 2013 Oct 15;263(1-2):116-20
pubmed: 23916392
Mult Scler. 1998 Jun;4(3):99-107
pubmed: 9762655
Clin Chim Acta. 2019 Oct;497:153-162
pubmed: 31351929
Mult Scler. 2016 Apr;22(4):502-10
pubmed: 26199348
J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):897-902
pubmed: 8057110
Eur J Neurol. 2018 Sep;25(9):1134-1139
pubmed: 29683546
Mult Scler. 2020 Jul;26(8):912-923
pubmed: 31066634
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Clin Chem Lab Med. 2018 Jun 27;56(7):1071-1080
pubmed: 29455184
Int J Mol Sci. 2018 Nov 29;19(12):
pubmed: 30501024
PLoS One. 2014 Feb 25;9(2):e89945
pubmed: 24651567

Auteurs

Philipp Schwenkenbecher (P)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Franz Felix Konen (FF)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Ulrich Wurster (U)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Torsten Witte (T)

Department of Clinical Immunology & Rheumatology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Stefan Gingele (S)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Kurt-Wolfram Sühs (KW)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Martin Stangel (M)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Thomas Skripuletz (T)

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hanover, Germany.

Classifications MeSH